These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32907434)

  • 41. Heparanase: structure, biological functions, and inhibition by heparin-derived mimetics of heparan sulfate.
    Vlodavsky I; Ilan N; Naggi A; Casu B
    Curr Pharm Des; 2007; 13(20):2057-73. PubMed ID: 17627539
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Design and synthesis of novel imidazole-substituted dipeptide amides as potent and selective inhibitors of Candida albicans myristoylCoA:protein N-myristoyltransferase and identification of related tripeptide inhibitors with mechanism-based antifungal activity.
    Devadas B; Freeman SK; Zupec ME; Lu HF; Nagarajan SR; Kishore NS; Lodge JK; Kuneman DW; McWherter CA; Vinjamoori DV; Getman DP; Gordon JI; Sikorski JA
    J Med Chem; 1997 Aug; 40(16):2609-25. PubMed ID: 9258368
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
    Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
    J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of natural products as selective PTP1B inhibitors via virtual screening.
    Yang Y; Tian JY; Ye F; Xiao Z
    Bioorg Chem; 2020 May; 98():103706. PubMed ID: 32199302
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The heparanase inhibitor PG545 is a potent anti-lymphoma drug: Mode of action.
    Weissmann M; Bhattacharya U; Feld S; Hammond E; Ilan N; Vlodavsky I
    Matrix Biol; 2019 Apr; 77():58-72. PubMed ID: 30096360
    [TBL] [Abstract][Full Text] [Related]  

  • 46. IRAK-4 inhibitors. Part 1: a series of amides.
    Buckley GM; Gowers L; Higueruelo AP; Jenkins K; Mack SR; Morgan T; Parry DM; Pitt WR; Rausch O; Richard MD; Sabin V; Fraser JL
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3211-4. PubMed ID: 18474425
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Aspirin Inhibits Cancer Metastasis and Angiogenesis via Targeting Heparanase.
    Dai X; Yan J; Fu X; Pan Q; Sun D; Xu Y; Wang J; Nie L; Tong L; Shen A; Zheng M; Huang M; Tan M; Liu H; Huang X; Ding J; Geng M
    Clin Cancer Res; 2017 Oct; 23(20):6267-6278. PubMed ID: 28710312
    [No Abstract]   [Full Text] [Related]  

  • 48. The development of inhibitors of heparanase, a key enzyme involved in tumour metastasis, angiogenesis and inflammation.
    Ferro V; Hammond E; Fairweather JK
    Mini Rev Med Chem; 2004 Aug; 4(6):693-702. PubMed ID: 15279603
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Heparanase and cancer progression: New directions, new promises.
    Arvatz G; Weissmann M; Ilan N; Vlodavsky I
    Hum Vaccin Immunother; 2016 Sep; 12(9):2253-6. PubMed ID: 27054564
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Structure-based optimization of potent 4- and 6-azaindole-3-carboxamides as renin inhibitors.
    Scheiper B; Matter H; Steinhagen H; Böcskei Z; Fleury V; McCort G
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5480-6. PubMed ID: 21840218
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Identification of potent inhibitors of DNA methyltransferase 1 (DNMT1) through a pharmacophore-based virtual screening approach.
    Krishna S; Shukla S; Lakra AD; Meeran SM; Siddiqi MI
    J Mol Graph Model; 2017 Aug; 75():174-188. PubMed ID: 28582695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Syntheses of novel azasugar-containing mimics of heparan sulfate fragments as potential heparanase inhibitors.
    Allen KA; Brown RL; Norris G; Tyler PC; Watt DK; Zubkova OV
    Carbohydr Res; 2010 Sep; 345(13):1831-41. PubMed ID: 20630499
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Identification of benzothiophene amides as potent inhibitors of human nicotinamide phosphoribosyltransferase.
    Chen W; Dong G; He S; Xu T; Wang X; Liu N; Zhang W; Miao C; Sheng C
    Bioorg Med Chem Lett; 2016 Feb; 26(3):765-768. PubMed ID: 26755394
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Involvement of Heparanase in the Pathogenesis of Mesothelioma: Basic Aspects and Clinical Applications.
    Barash U; Lapidot M; Zohar Y; Loomis C; Moreira A; Feld S; Goparaju C; Yang H; Hammond E; Zhang G; Li JP; Ilan N; Nagler A; Pass HI; Vlodavsky I
    J Natl Cancer Inst; 2018 Oct; 110(10):1102-1114. PubMed ID: 29579286
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Chemical modifications of heparin that diminish its anticoagulant but preserve its heparanase-inhibitory, angiostatic, anti-tumor and anti-metastatic properties.
    Lapierre F; Holme K; Lam L; Tressler RJ; Storm N; Wee J; Stack RJ; Castellot J; Tyrrell DJ
    Glycobiology; 1996 Apr; 6(3):355-66. PubMed ID: 8724143
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dendrimer Heparan Sulfate Glycomimetics: Potent Heparanase Inhibitors for Anticancer Therapy.
    Zubkova OV; Ahmed YA; Guimond SE; Noble SL; Miller JH; Alfred Smith RA; Nurcombe V; Tyler PC; Weissmann M; Vlodavsky I; Turnbull JE
    ACS Chem Biol; 2018 Dec; 13(12):3236-3242. PubMed ID: 30480427
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of VHR phosphatase inhibitors with micromolar activity based on structure-based virtual screening.
    Park H; Jung SK; Jeong DG; Ryu SE; Kim SJ
    ChemMedChem; 2008 Jun; 3(6):877-80. PubMed ID: 18236492
    [No Abstract]   [Full Text] [Related]  

  • 58. Identification and characterization of heparin/heparan sulfate binding domains of the endoglycosidase heparanase.
    Levy-Adam F; Abboud-Jarrous G; Guerrini M; Beccati D; Vlodavsky I; Ilan N
    J Biol Chem; 2005 May; 280(21):20457-66. PubMed ID: 15760902
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Identification of potent VHZ phosphatase inhibitors with structure-based virtual screening.
    Park H; Park SY; Oh JJ; Ryu SE
    J Biomol Screen; 2013 Feb; 18(2):226-31. PubMed ID: 23042075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Roneparstat: Development, Preclinical and Clinical Studies.
    Noseda A; Barbieri P
    Adv Exp Med Biol; 2020; 1221():523-538. PubMed ID: 32274725
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.